PR about to drop any day now: We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.” “As well, we have corresponded in regards to the FDA testing procedures on our TSW pain cream and they continue to progress to what we feel will be near-term completion.” http://risingbiosciences.com/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.